Evoke Pharma (EVOK) Tops Q2 EPS by 2c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. AMGN
3. BKNG
4. DOX
5. DUOL
6. ANET
7. XYZ
8. SWKS
9. FISV
10. CVS

Go back to Evoke Pharma (EVOK) Tops Q2 EPS by 2c

Noble Financial Keeps Evoke Pharma (EVOK) at 'Hold' Following Q2 Numbers; Still Awaiting Development Plans

August 16, 2016 8:43 AM EDT

Noble Financial affirms Evoke Pharma (Nasdaq: EVOK) with a Hold rating following Q2 results issued Monday night.

Analyst Nathan Cali noted the following on Tuesday:

Operational costs incrementally lower. August 15th, 2016, reported second quarter financial results; no revenues as expected; SG&A $802,655... More

FBR Capital Reiterates Outperform on Evoke Pharma (EVOK) Following 2Q Report

August 16, 2016 8:42 AM EDT

FBR Capital reiterated an Outperform rating and $9.00 price target on Evoke Pharma (NASDAQ: EVOK) following the company's 2Q earnings report. EVOK reported a 2Q16 net loss of $3.0 million, or ($0.41)/ share, versus estimates of a net loss of $3.4 million, or ($0.47)/share.

Analyst Vernon Bernardino commented, "On... More